Medications

Technology assesses effectiveness and safety of drug targets

Researchers have boosted pioneering technology to show whether potential treatments are worth progressing into human trials, in a game-changing move that could dramatically reduce the high failure rates in drug discovery ...

Medical research

Unique binding of delta variant may explain high transmissibility

Unlike other SARS-CoV-2 variants, the delta variant can attach to copies of itself, forming larger aggregations, or clumps, of viral particles, suggests a study by scientists at the National Institutes of Health. The researchers ...

Diseases, Conditions, Syndromes

Scientists develop test that easily detects variants causing COVID-19

Rutgers scientists have developed a lab test that can quickly and easily identify which variant of the virus causing COVID-19 has infected a person, an advance expected to greatly assist health officials tracking the disease ...

Diseases, Conditions, Syndromes

The RTS,S malaria vaccine may do more than we thought

Antibodies induced by the RTS,S malaria vaccine can bind strongly to other P. falciparum antigens not contained in the vaccine, and this is associated with greater vaccine protection, according to a new study published in ...

Diseases, Conditions, Syndromes

New targets uncovered for treating hypertension-related fibrosis

Elevated blood pressure can cause a condition known as perivascular fibrosis, where the outside wall of a blood vessel thickens due to connective tissue build-up. Although recent data has suggested that the thickening is ...

Oncology & Cancer

Tumors partially destroyed with sound don't come back

Noninvasive sound technology developed at the University of Michigan breaks down liver tumors in rats, kills cancer cells and spurs the immune system to prevent further spread—an advance that could lead to improved cancer ...

page 23 from 40